Inputs: momentum, trendVelocity
Mixed signal: momentum 57/100, trend 72/100.
Prediction result · Ensemble engineUpdated 5:41 AM
PVLAPalvella Therapeutics, Inc. stock price outlook
$146.15-3.58% since prev closeNeutral
Palvella Therapeutics, Inc. (PVLA) is trading at $146.15, down 3.58% since the previous close and +16.83% over the past week. Price sits above its 50-day average by 3.31%, with price momentum at 57/100 and trend velocity at 72/100. Sentiment across 5 recent headlines reads net constructive at 59/100. Volatility risk is elevated (86/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
PVLA
Palvella Therapeutics, Inc.
$146.15-3.58%
LEANNEUTRAL / wait for cleaner tape
WHY
- Palvella Therapeutics, Inc. (PVLA) is trading at $146.15, down 3.58% since the previous close and +16.83% over the past week. Price sits above its 50-day average by 3.31%, with price momentum at 57/100 and trend velocity at 72/100. Sentiment across 5 recent headlines reads net constructive at 59/100. Volatility risk is elevated (86/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
- Bull input: Oscillator at 65 — healthy uptrend region.
- Bear input: No bearish case in the sources.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Playable
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
5 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment59/100
Price Momentum57/100
Trend Velocity72/100
Volatility Risk86/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Palvella Therapeutics, Inc. (PVLA) is trading at $146.15, down 3.58% since the previous close and +16.83% over the past week. Price sits above its 50-day average by 3.31%, with price momentum at 57/100 and trend velocity at 72/100. Sentiment across 5 recent headlines reads net constructive at 59/100. Volatility risk is elevated (86/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on PVLA
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 59/100 + price -3.6% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 51/100 with price drift -3.6% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 86/100 is too high to trust either direction without confirmation.
Inputs: pctOfRange, trendVelocity
Near range top — needs fresh catalyst to break out.
Inputs: newsSentiment, weekChange
Sentiment 59/100 vs week change 16.8% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 3.3% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 65 — healthy uptrend region.
Inputs: momentum, dayChange, vsSma50
Momentum 57/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 59/100 and weekly change 16.8% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 51/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 86/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 83% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 59/100 and momentum 57/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
Price is above the 50d SMA and both momentum and trend velocity are holding up.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 65 does not show a rebound edge.
Why the ensemble agrees
- Vol regime 86/100 is too high to trust either direction without confirmation.
- Mixed signal: momentum 57/100, trend 72/100.
- Near range top — needs fresh catalyst to break out.
Counter-trees
- Price is above the 50d SMA and both momentum and trend velocity are holding up.
- Oscillator at 65 — healthy uptrend region.
Bull Case
- Oscillator at 65 — healthy uptrend region.
- Price is above the 50d SMA and both momentum and trend velocity are holding up.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo! Finance Canada60
Palvella Therapeutics, Inc. (PVLA) Stock Price, News, Quote & History - Yahoo! Finance Canada
10/30/2026, 10:47:24 PM
Yahoo Finance Singapore53
Palvella Therapeutics, Inc. (PVLA) stock price, news, quote and history - Yahoo Finance Singapore
10/29/2026, 10:23:50 AM
Moomoo57
Mizuho Securities Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Cuts Target Price to $232 - Moomoo
10/29/2026, 12:31:00 PM
Stock Titan63
One investor reports sole voting power over 1.1M Palvella Therapeutics (PVLA) shares. - Stock Titan
10/28/2026, 7:44:31 PM
Stock Traders Daily61
Avoiding Lag: Real-Time Signals in (PVLA) Movement - Stock Traders Daily
10/27/2026, 6:34:02 PM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Market cap
- $2.11B
- 52-week range
- $161.38/$71.55
- Volume
- 293,067
- Avg volume
- 220,688
- Analyst 1-yr target
- $225.50
- Exchange
- NASDAQ-GM
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 3 sells by PVLA insiders (SEC Form 4 filings)
- SELL Goin Kathleen Chief Operating Officer · 2026-10-23$253K
- SELL Goin Kathleen Chief Operating Officer · 2026-10-23$208K
- SELL Goin Kathleen Chief Operating Officer · 2026-10-23$77K
Earnings Intelligence
Next
Nov 5, 2026
Estimate
$-1.65
Actual
$-1.52
- • Last report Aug 4, 2026 (Jun 2026): EPS $-1.52 vs $-1.16 expected, -31.03% surprise.
- • Beat estimates in 0 of the last 4 quarters.
- • Next report expected Nov 5, 2026, consensus EPS $-1.65 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • High volatility — position sizing and stops matter more here.
- • Confirm liquidity, spreads, and your own thesis before acting.
PVLA questions
What is the MarketPicks AI signal for Palvella Therapeutics, Inc. stock (PVLA)?
As of Nov 2, 12:41 AM ET, the ensemble reads neutral on PVLA — no consensus — 14 of 16 bots holding, with 2 bull, 0 bear and 14 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest PVLA price on MarketPicks?
PVLA was $146.15 on the latest quote (Nov 2, 12:41 AM ET), -3.58% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for PVLA mean?
Scores run from 0 to 100, with 50 neutral. PVLA shows momentum 57/100, trend velocity 72/100 and volatility risk 86/100, with news sentiment at 59/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.